Again I will say this because it was one very short paragraph at the end of all the other stuff...
FDA want better potency metrics and I tend to think this may be the big issue.
just because msb put it second in the statement doesnt mean that's where it was on the CRL. Remember that release was a salvage job, not the actual letter they received.
MSB to dispute FDA finding in Type A meeting, page-23
-
- There are more pages in this discussion • 995 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.18 | $2.321M | 1.942M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4134 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 52429 | 8 |
View Market Depth
| Last trade - 11.14am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |